Will Ceftazidime/Avibactam Plus Aztreonam be Effective for NDM and OXA-48-Like Producing Organisms: Lessons Learnt from In vitro Study-Reference-Cited by-同舟云学术

Will Ceftazidime/Avibactam Plus Aztreonam be Effective for NDM and OXA-48-Like Producing Organisms: Lessons Learnt from In vitro Study

Published:2019-01 Issue:1 Volume:37 Page:34-41
ISSN:0255-0857
Container-title:Indian Journal of Medical Microbiology
language:en
Short-container-title:Indian Journal of Medical Microbiology

Author:

Pragasam Agila Kumari,Veeraraghavan Balaji,Shankar Baby Abirami,Bakthavatchalam Yamuna Devi,Mathuram Alice,George Biju,Chacko Binila,Korula Pritish,Anandan Shalini

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference43 articles.

1. Minocycline and tigecycline: What is their role in the treatment of carbapenem-resistant gram-negative organisms?;Shankar;Microb Drug Resist,2017

2. Clinical and bacterial risk factors for mortality in children with carbapenem-resistant Enterobacteriaceae bloodstream infections in India;Nabarro;Pediatr Infect Dis J,2017

3. Klebsiella pneumoniae: Going on the offense with a strong defense;Paczosa;Microbiol Mol Biol Rev,2016

4. Emergence of ST147 Klebsiella pneumoniae carrying blaNDM-7 on IncA/C2 with ompK35 and ompK36 mutations in India;Shankar;J Infect Public Health,2019

5. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience;Veeraraghavan;Pathog Glob Health,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of in vitro antimicrobial activity of ceftazidime-avibactam and phenotypic synergy testing with aztreonam against carbapenem resistant Gram-negative bacilli in a tertiary care hospital;Journal of Laboratory Physicians;2024-07-10

2. In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases–co-producing carbapenem-resistant Enterobacter cloacae complex;European Journal of Clinical Microbiology & Infectious Diseases;2024-05-03

3. A Study on Ceftazidime/Avibactam and Aztreonam Synergy Among Aztreonam Resistant Metallo-β-lactamase Producing Enterobacterales in a Tertiary Care Hospital;Mediterranean Journal of Infection Microbes and Antimicrobials;2024-02-15

4. Ceftazidime-avibactam/aztreonam combination synergy against carbapenem-resistant Gram-negative isolates: In vitro study;Current Medicine Research and Practice;2024-01

5. Are we looking towards an early demise of ceftazidime/avibactam (CAZ/AVI) as an antibiotic?;Indian Journal of Medical Microbiology;2023-11